XTL Biopharmaceuticals Ltd. AGM Postponed Until November 1, 2006
26 October 2006 - 3:32AM
PR Newswire (US)
NEW YORK, October 25 /PRNewswire-FirstCall/ -- XTL
Biopharmaceuticals Ltd. (NASDAQ:XTLB)(LSE:XTL)(TASE:XTL) announces
today that its Annual General Meeting ("AGM") was postponed for one
week in accordance with its articles of association due to the
absence of a quorum. The postponed AGM will take place at the
Company, Building 3, Kiryat Weizmann Science Park, Rehovot, PO Box
370, Israel 76100 at 4:00 p.m. on November 1, 2006. Any proxy votes
received at any time up to 48 hours prior to the postponed AGM will
be included in the total votes counted for the AGM. Those
shareholders who have a valid "proof of ownership" in Israel or a
letter of representation from Computershare, the Company's
registrars, and attend the meeting in person will also be permitted
to vote. ABOUT XTL BIOPHARMACEUTICALS LTD. XTL Biopharmaceuticals
Ltd. ("XTL") is engaged in the acquisition, development and
commercialization of therapeutics for the treatment of infectious
diseases, with a focus on hepatitis C. XTL is developing XTL-2125 -
a small molecule, non-nucleoside inhibitor of the hepatitis C virus
polymerase. XTL-2125 is currently in a Phase 1 clinical trial in
patients with chronic hepatitis C. XTL is also developing XTL-6865
- a combination of two monoclonal antibodies against the hepatitis
C virus - presently in Phase 1 clinical trials in patients with
chronic hepatitis C. XTL's hepatitis C pipeline also includes
several families of pre-clinical hepatitis C small molecule
inhibitors. XTL also has an active in-licensing and acquisition
program designed to identify and acquire additional drug
candidates. XTL is publicly traded on the NASDAQ, London, and
Tel-Aviv Stock Exchanges (NASDAQ:XTLB)(LSE:XTL)(TASE:XTL). Contact
details: Ron Bentsur, Chief Executive Officer Tel:
+1-(212)-531-5960 DATASOURCE: XTL Biopharmaceuticals Ltd CONTACT:
Contact details: Ron Bentsur, Chief Executive Officer Tel:
+1-(212)-531-5960
Copyright
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
From Jun 2024 to Jul 2024
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
From Jul 2023 to Jul 2024